Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial.

Schlenk RF, Montesinos P, Kim HJ, Romero-Aguilar A, Vrhovac R, Patkowska E, Žak P, Wang PN, Hanyok J, Liu L, Kamel YM, Imadalou K, Lesegretain A, Cortes J, Sekeres MA, Dombret H, Amadori S, Wang J, Perl AE, Levis MJ, Erba HP

Open source

DOI: 10.3324/haematol.2024.286623
Published: 2025 Sep 1
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2024.286623,
  title = {Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial.},
  author = {Schlenk RF and Montesinos P and Kim HJ and Romero-Aguilar A and Vrhovac R and Patkowska E and Žak P and Wang PN and Hanyok J and Liu L and Kamel YM and Imadalou K and Lesegretain A and Cortes J and Sekeres MA and Dombret H and Amadori S and Wang J and Perl AE and Levis MJ and Erba HP},
  year = {2025},
  journal = {Haematologica},
  doi = {10.3324/haematol.2024.286623},
  url = {https://doi.org/10.3324/haematol.2024.286623}
}

RIS

TY  - JOUR
TI  - Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial.
AU  - Schlenk RF
AU  - Montesinos P
AU  - Kim HJ
AU  - Romero-Aguilar A
AU  - Vrhovac R
AU  - Patkowska E
AU  - Žak P
AU  - Wang PN
AU  - Hanyok J
AU  - Liu L
AU  - Kamel YM
AU  - Imadalou K
AU  - Lesegretain A
AU  - Cortes J
AU  - Sekeres MA
AU  - Dombret H
AU  - Amadori S
AU  - Wang J
AU  - Perl AE
AU  - Levis MJ
AU  - Erba HP
PY  - 2025
JO  - Haematologica
DO  - 10.3324/haematol.2024.286623
UR  - https://doi.org/10.3324/haematol.2024.286623
ER  -

APA

RF, S., P, M., HJ, K., A, R., R, V., E, P., P, Ž., PN, W., J, H., L, L., YM, K., K, I., A, L., J, C., MA, S., H, D., S, A., J, W., AE, P., MJ, L., & HP, E. (2025). Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial.. Haematologica. https://doi.org/10.3324/haematol.2024.286623

Source records

pubmed · retrieved 2026-09-26T23:03:51.946Z